安裝中文字典英文字典辭典工具!
安裝中文字典英文字典辭典工具!
|
- Brukinsa: Uses, Dosage, Side Effects, Warnings - Drugs. com
Brukinsa is a targeted treatment, not a chemotherapy drug, and works by directly blocking an enzyme, called Bruton’s tyrosine kinase (BTK), preventing its activity
- BRUKINSA® (zanubrutinib) BTK Inhibitor | For Patients
BRUKINSA® (zanubrutinib) is a BTKi that treats adults with CLL SLL, WM, MCL, MZL, and FL See Important Safety Information and Prescribing Information
- Brukinsa (zanubrutinib) - Uses, Side Effects, and More
Find patient medical information for Brukinsa (zanubrutinib) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings
- Zanubrutinib - Wikipedia
In September 2021, the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Brukinsa, intended for the treatment of Waldenström's macroglobulinaemia [28]
- BeOne Medicines Establishes Standard for Long-Term Disease Control in . . .
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapy BRUKINSA plus next
- Zanubrutinib (oral route) - Side effects dosage - Mayo Clinic
Zanubrutinib is used to treat mantle cell lymphoma (MCL) in patients who have received at least one previous treatment for their cancer This medicine is also used to treat Waldenström macroglobulinemia (WM)
- BRUKINSA Patient Brochure
For information about how BRUKINSA was shown to be effective against your disease, talk to your doctor or visit BRUKINSA com
- Brukinsa: Side Effects and How to Manage Them - Healthline
Brukinsa treats multiple types of blood cancers Learn about serious side effects, such as heart issues, bleeding, infections, and changes in blood count
|
|
|